首页/数据集/Additional file 2 of Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization

Additional file 2 of Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization

NIAID Data Ecosystem2026-05-02 收录

药物靶点孟德尔随机化

自身免疫性疾病脂质修饰药物靶点

数据链接：

https://figshare.com/articles/dataset/Additional_file_2_of_Identification_of_lipid-modifying_drug_targets_for_autoimmune_diseases_insights_from_drug_target_mendelian_randomization/26085200 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Material 2

应用场景：

创建时间：

2024-06-22

药物靶点孟德尔随机化

跨血统心血管药物疗效评估

CETP correlation matrices in the East Asian and European populations (GRCh37) used for linkage disequilibrium pruning. These correlation matrices and summary statistics for LDL-C and HDL-C from Global

DataCite Commons2023-11-16 更新60

Genetically proxied IL4/IL-13 inhibition was not associate with the risk of cutaneous T-cell lymphoma: Drug-Target Mendelian Randomization Analyses

药物靶点孟德尔随机化

皮肤T细胞淋巴瘤

This study aimed to delve into the potential causal nexus between dupilumab and cutaneous T-cell lymphomas (CTCL), leveraging publicly accessible, anonymized summary data sourced from prior genome-wid

Mendeley Data50

Additional file 1 of Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study

药物靶点孟德尔随机化

青少年降脂药物安全性

Additional file 1. Table S1. The primary efficacy outcomes from the “Children of 1997” birth cohort. Table S2. The safety outcomes from the “Children of 1997” birth cohort. Table S3. The genetic varia

Figshare2024-08-16 更新50

Supplementary Material for: Drug Target Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Atrial Fibrillation

药物靶点孟德尔随机化

心房颤动风险遗传评估

Introduction: Atrial fibrillation (AF) is a prevalent cardiac arrhythmia with significant clinical implications. The potential influence of lipid-lowering therapies, specifically PCSK9 inhibitors (PCS

Figshare2024-03-26 更新60

Additional file 1 of Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study

药物靶点孟德尔随机化

炎症性肠病遗传学

Additional file 1: Table S1. Information of eQTL and GWAS summary data. Table S2. SMR association between expression of gene HMGCR, PCSK9, or NPC1L1 and inflammatory bowel diseases. Table S3. IVW-MR a

NIAID Data Ecosystem50

Additional file 2 of Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization

资源简介：

相关数据集